News for Eton Pharmaceuticals, Inc. (ETON)

Published at

Jul 24, 2025 4:31 AM

by gurufocus.com

positive

positive

BlackRock, Inc. Expands Stake in Eton Pharmaceuticals Inc.

On June 30, 2025, BlackRock, Inc. (Trades, Portfolio) executed a notable transaction by acquiring an additional 1,184,997 shares of Eton Pharmaceuticals Inc. at

MSFTD.BA MSFTCL.SN MSFTC.BA MSFTB.BA MSFT.MI ETON BLQA.DE BLK.MX AMZNCL.SN AMZN AAPLD.BA AAPLCL.SN AAPLC.BA AAPL.SN AAPL.BA AAPL 0QZZ.L

Read more →
Published at

Jul 18, 2025 8:09 PM

by gurufocus.com

positive

positive

Eton Pharmaceuticals Inc (ETON) Shares Up 8.03% on Jul 18

Shares of Eton Pharmaceuticals Inc (ETON) surged 8.03% in mid-day trading on Jul 18. The stock reached an intraday high of $15.27, before settling at $15.07,

ETON

Read more →
Published at

Jul 8, 2025 12:54 PM

by manilatimes.net

positive

positive

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)

- NDA assigned a Target Action Date of February 25, 2026 -

ETON

Read more →
Published at

Jun 27, 2025 2:15 PM

by gurufocus.com

positive

positive

Eton Pharmaceuticals (ETON) to Join Russell 3000 and 2000 Indexes | ETON Stock News

Eton Pharmaceuticals (ETON) has revealed that it will be included in the Russell 3000 and Russell 2000 Indexes. This inclusion will take effect following the co

ETON

Read more →
Published at

Jun 18, 2025 3:41 AM

by gurufocus.com

positive

positive

Opaleye Management Inc. Increases Stake in Eton Pharmaceuticals Inc.

On June 10, 2025, Opaleye Management Inc. (Trades, Portfolio) executed a strategic stock transaction involving Eton Pharmaceuticals Inc. The firm added 2,930 sh

SNWV RYTM.MX RYTM ETON

Read more →
Published at

Jun 17, 2025 1:05 AM

by gurufocus.com

positive

positive

Insider Sell: David Krempa Sells 34,000 Shares of Eton Pharmaceuticals Inc (ETON)

On June 16, 2025, David Krempa, Chief Business Officer of Eton Pharmaceuticals Inc (ETON), sold 34,000 shares of the company, according to a SEC Filing. Followi

ETON

Read more →
Published at

Jun 6, 2025 3:04 AM

by gurufocus.com

positive

positive

Insider Sell: Sean Brynjelsen Sells 210,000 Shares of Eton Pharmaceuticals Inc (ETON)

On June 5, 2025, Sean Brynjelsen, President & CEO, 10% Owner of Eton Pharmaceuticals Inc (ETON), sold 210,000 shares of the company. Following this transaction,

ETON

Read more →
Published at

May 29, 2025 8:12 PM

by gurufocus.com

neutral

neutral

Eton Pharmaceuticals Inc (ETON) Shares Down 4.98% on May 29

Shares of Eton Pharmaceuticals Inc (ETON) fell 4.98% in mid-day trading on May 29. The stock reached an intraday low of $18.75, before recovering slightly to

ETON

Read more →
Published at

May 29, 2025 1:47 PM

by gurufocus.com

positive

positive

Eton Pharmaceuticals (ETON) Price Target Raised After FDA Approval | ETON Stock News

H.C. Wainwright has increased its price target for Eton Pharmaceuticals (ETON) from $33 to $35, maintaining its Buy rating on the stock. This adjustment follows

ETON

Read more →
Published at

May 29, 2025 5:49 AM

by insidermonkey.com

neutral

neutral

Eton Pharmaceuticals, Inc. (ETON) Launches Game-Changer for Adrenal Insufficiency

Eton Pharmaceuticals, Inc.

ETON

Read more →
Published at

May 29, 2025 12:46 AM

by gurufocus.com

positive

positive

Eton Pharmaceuticals (ETON) Gains FDA Approval for New Pediatric Therapy | ETON Stock News

Eton Pharmaceuticals (ETON) has secured approval from the U.S. Food and Drug Administration for KHINDIVI Oral Solution, a new treatment designed for children ag

ETON

Read more →
Published at

May 28, 2025 11:45 PM

by manilatimes.net

positive

positive

Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution

**media[639800]**

ETON

Read more →
Published at

May 21, 2025 8:57 AM

by seekingalpha.com

neutral

neutral

Eton Pharmaceuticals Set To Dominate Orphan Drug Niche (NASDAQ:ETON)

Eton Pharmaceuticals is able to buy orphan drugs from large pharma companies, where they are too small to matter. Read why ETON stock should be bought now.

ETON

Read more →
Published at

May 19, 2025 8:13 PM

by gurufocus.com

positive

positive

Eton Pharmaceuticals Inc (ETON) Shares Up 3.33% on May 19

Shares of Eton Pharmaceuticals Inc (ETON) surged 3.33% in mid-day trading on May 19. The stock reached an intraday high of $19.85, before settling at $19.56,

ETON

Read more →
Published at

May 14, 2025 10:37 PM

by manilatimes.net

positive

positive

Eton Pharmaceuticals to Participate at Upcoming Investor Conferences

**media[626262]**

ETON

Read more →
Published at

May 14, 2025 9:17 AM

by gurufocus.com

positive

positive

Eton Pharmaceuticals Inc (ETON) Q1 2025 Earnings Call Highlights: Revenue Soars 117% Amid Strong Product Sales and Strategic Relaunches

Revenue: $17.3 million in Q1 2025, up 117% from $8.0 million in Q1 2024.Product Sales: $14.0 million in Q1 2025, a 76% increase from $8.0 million in Q1 2024.Li

ETON

Read more →
Published at

May 14, 2025 7:08 AM

by gurufocus.com

positive

positive

Q1 2025 Eton Pharmaceuticals Inc Earnings Call Transcript

May 13, 2025 / 08:30PM GMTOperator Good afternoon, and welcome to the Eton Pharmaceuticals first-quarter 2025 financial results conference call. (Operator Instr

ETON

Read more →
Published at

May 14, 2025 5:56 AM

by gurufocus.com

positive

positive

Eton Pharmaceuticals (ETON) Projects Strong Growth with New Acquisitions

Key Takeaways: Eton Pharmaceuticals (ETON) is experiencing significant growth due to strategic acquisitions. Analysts predict a notable increase in stock

ETON

Read more →
Published at

May 14, 2025 12:00 AM

by gurufocus.com

positive

positive

Eton Pharmaceuticals Reports First Quarter 2025 Financial Results

Q1 2025 revenue of $17.3 million, with product sales of $14.0 million, representing 76% growth over Q1 2024 and the 17th straight quarter of sequential product

ETON

Read more →
Published at

May 13, 2025 11:15 PM

by zacks.com

negative

negative

Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates

Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of -22.22% and 6.71%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

ETON

Read more →